Novel organoid models of cervical cancer and a healthy human cervix have been developed to study the condition and its progression.
List view / Grid view
Researchers have demonstrated that blocking CD47-mediated signalling in mice can enhance the speed of pathogen clearance, presenting a new potential form of immunotherapy.
Drug Target Review spoke with CUE Biopharma’s President and CSO to find out how and why they created the ImmunoSTAT platform and the ways it may benefit drug design in the future.
A study that teases apart the biological mechanisms by which HPV cause cancer, has found a strategy that may provide targeted treatment...
18 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The grant for the second year of a multi-year R+D project and will be used for Hookipa’s arenaviral vector technologies, cancer immunotherapies and to...